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ABSTRACT
Breast cancer is the most deadly case for women. One of the causes is duration of hormonal contraception 
use. The purpose is to determine correlation of duration hormonal contraception use with breast cancer cases. 
Study design used analytic correlation with a cross-sectional method. The population is all users of hormonal 
contraception	at	RSUD	Jombang	(396	people).	The	sample	size	used	purposive	sampling	technique	with	
364	respondents.	Independent	variable	is	duration	of	hormonal	contraception	use	and	dependent	variable	is	
breast	cancer	cases.	Furthermore,	analysis	test	used	chi-square	with	α	=	0.05.	The	result	indicated	that	60	
(48.1%)	from	125	respondents	using	hormonal	contraception	>5	years	had	got	breast	cancer.	However,	all	
of	239	respondents	(65.8%)	t	using	hormonal	contraception	<5	years	did	not	get	breast	cancer.	The	result	of	
chi-square	is	p	=	0.000	<0.005,	which	means	strong	correlation	of	duration	hormonal	contraception	use	with	
breast	cancer	cases.	The	conclusion	is	hormonal	contraceptive	use	>5	years	will	increase	the	risk	of	breast	
cancer cases.
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Introduction
Breast cancer is a type of cancer which often occurs 
in	women	in	Indonesia.	The	risk	factors	for	breast	cancer	
are,	age>	50	years,	alcohol	consumption,	obesity,	giving	
birth	at	the	age	of	more	than	35	years,	never	giving	birth,	
not	 breastfeeding,	 menopause	 at	 age>	 50	 years,	 early	
menarche,	 radiation	 exposure,	 and	 the	 long	 term	 use	
of hormonal contraception.1 The hormone is exposure 
to sex hormones such as estrogen and progesterone in 
which excessive amount interferes with physiological 
processes	in	the	body,	including	mammary	tissue.2
Based on the Hospital Information System (SIRS) in 
2014,	the	number	of	outpatients	and	inpatients	(12.8%)	
had	breast	cancer	as	many	as	12,014	people	(28.7%)	and	
cervical	cancer	with	 total	5,349	people.3 Breast cancer 
had a contribution of 30% and is the most dominant 
in	 Indonesia,	 outstripping	 cervical	 cancer	 or	 cervical	
cancer which contributes24%.4 The mortality rate from 
breast cancer is high in developed countries and it is 
still	 low	in	developing	countries,	 including	Indonesia.3 
Based on early detection of breast cancer in Indonesia as 
of	2016,	the	number	of	breast	cancer	patients	was	4,030	
people with those surviving cervical cancer numbering 
1,739	people.5 Based on breast cancer data in Jombang 
Hospital	in	2017	there	were	31	people	with	breast	cancer.
Many	factors	can	cause	breast	cancer,	one	of	them	
is the use of hormonal contraception. It is a part of a 
program	known	as	family	planning	which	is	an	attempt	
to delay pregnancy or determine the number of or time 
between pregnancy using contraception.6 According 
to	 the	World	Health	Organization	 (WHO),	 nearly	 380	
million	couples	used	family	planning	and	65-75	million	
of them used hormonal contraception such as oral 
contraceptives,	 injections	 and	 implants.7	 Data of the 
National	Population	and	Family	Planning	Board	showed	
that the choice of contraception was the most interested 
or	 chosen	 by	 new	 and	 active	 family	 planning	 users,	
namely	 pills	 and	 injections.1 Data from the national 
population	and	family	planning	body	(BKKBN)	in	2013	
received	 8,500,247	 couples	 of	 reproductive	 age	 who	
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were	 new	 family	 planning	 participants,	 with	 details	
of	 injectable	 contraceptive	 use	 4,128,115	 participants	
(48.56%),	 pills	 as	 many	 as	 2,261,480	 participants	 (2,	
60%),	 implants	 were	 784,215	 participants	 (9.23%),	
condoms	were	517,638	participants	(6.09),	 intrauterine	
contraception	 658,632	 participants	 (7.75%),	 MOW	
(female	surgery	method)	128,793	participants	(1.52%),	
MOP	(male	surgery	method)	21,37	participants	(0.25%).	
From	the	above	data,	we	can	see	 that	 the	most	widely	
used is hormonal contraceptive methods.8	 In	 addition,	
data	from	the	health	profile	of	Jombang	district,	showed	
that the type of contraception used by acceptors is 
injection	KB,	as	much	as	61.9%,	followed	by	pills	and	
implants.7 Previous studies had shown that there was a 
correlation between the use of hormonal contraception 
and the incidence of breast cancer.9 
Some studies suggest that the use of hormonal 
contraception	over	a	long	period	of	time	or	≥5	years	can	
increase	breast	cancer	 risk.	Women	who	use	hormonal	
birth	control	have	a	risk	of	2,990	times	more	likelihood	
of getting breast cancer.10 Other studies suggest that 
hormonal contraceptive use causes increased exposure 
to estrogen and progesterone hormones which can cause 
cell proliferation in the breast glands and inhibition of 
the apoptotic process.11	This,	hormonal	contrast	was	one	
of	the	risk	factors	for	breast	cancer.
Prevention	efforts	were	a	healthy	lifestyle,	counseling,	
and	also	early	detection	with	the	BSE	system	(check	your	
own breasts) to see whether there were lumps or other 
changes	 that	were	 a	 sign	 of	 breast	 cancer	 and	 required	
medical attention.12	Based	on	the	above	background,	the	
researchers are interested in conducting research related 
to the use of hormonal contraception with the occurrence 
of breast cancer in Jombang General Hospital.
Method
Study Design, Setting, and Sampling: The design 
of this study was cross-sectional analytic. Population 
was all hormonal contraceptive participants who used 
injections,	pills	and	 implants	 in	 the	Jombang	Hospital,	
as	many	as	396	people.	The	sample	size,	as	many	as	364,	
used	 purposive	 sampling	 technique.	 The	 independent	
variable was duration of hormonal contraceptive use 
and the dependent variable was breast cancer cases. The 
place and time of the study were the Jombang District 
Hospital,	9-15	May,	2018.
The	study	used	observations	and	used	the	chi-square	
statistical test
Results
Long usage of hormonal contraception
Table 1: Frequency distribution of respondents 
based on duration of hormonal contraceptive use at 
the Jombang Hospital Polyclinic,19-30 May, 2018
No. The duration of family planning Frequency
Percentage 
(%)
1. > 5 years 125 34.2
2. < 5 years 239 65.8
Total 364 100.0
Source: 2018 primary data
Table	 1	 shows	 that	 the	 majority	 of	 respondents	
(65.8%)	used	<5	years	hormonal	contraception,	as	many	
as	27	respondents.
Table 2: Characteristics of respondents based on the 
incidence of breast cancer
No. Incidence of breast cancer Frequency
Percentage 
(%)
1. Yes 60 16.5
2. No 304 83.5
Total 364 100.0
Source: 2018 primary data
Table 2 shows that almost all respondents (83.5%) 
did	not	have	breast	cancer,	as	many	as	364	respondents.
Correlation	 between	 the	 duration	 of	 hormonal	
contraceptive use and the incidence of breast cancer
Table 3: Cross=tabulation of the correlation between 
the duration of hormonal contraceptive use and 
the incidence of breast cancer in the Gynecology 
Department of Jombang Hospital on 19-30May, 2018
Hormonal 
Usage
Breast cancer history
Total
Yes No
∑ % ∑ % ∑ %
> 5 Years 60 48.1 65 51.9 125 100
< 5 Years 0 0 239 100 239 100
Source : primary data 2018
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Based	on	Table	3,	12	of	the	52	respondents	who	used	
<5	years	of	Hormonal	KB	all	100%	had	no	breast	cancer.
Discussion
Long usage of hormonal contraception: Table 1 
shows	 that	most	 (65.8%)	of	 the	 older	 respondents	 use	
hormonal	contraception	<	5	years,	as	many	as	27	people.	
Previous	theory	mentioned	that	nearly	70%	of	acceptors	
used hormonal contraception methods.13 The duration 
of use of hormonal contraception depended on the type 
of contraception which was used every day for many 
years,	but	there	were	also	many	side	effects	complained	
about by family planning acceptors because they uses 
hormonal contraception methods.
According	 to	 researchers,	 some	 respondents	
used hormonal contraception <5 years because the 
contraception which was chosen was inappropriate 
or	 unsuitable,	 so	 they	 replaced	 it	with	 other	 hormonal	
contraceptives for a period of <5 years.
Based	 on	 the	 results	 of	 the	 study,	 it	 was	 shown	
that	 almost	 all	 (77.2%)	 of	 the	 respondents	 obtained	
information,	 as	 many	 as	 66	 people.	 The	 delivery	
of information or messages about family planning 
programs	can	use	radio,	TV,	and	promotion	with	the	aim	
of problem solving within the community to improve or 
achieve family planning programs.14 Information on the 
selection of appropriate contraception types and good 
time periods can be obtained by consulting a doctor or 
health	worker.	
According	 to	 the	 researchers,	 the	 information	
obtained	 by	 respondents	 about	 KB	 programs	 and	
hormonal contraceptives was obtained from many 
various sources. Before starting a plan to use hormonal 
contraception,	 the	 acceptor	 candidates	 will	 be	 given	
information	 on	 the	 types	 of	 side	 effects	 and	 how	 to	
overcome them.
Based	 on	 the	 results	 of	 the	 study,	 it	 showed	 that	
the	 majority	 (53.2%)	 of	 respondents	 used	 injectable	
contraception	type,	as	many	as	42	people.	This	can	be	due	
to	the	benefits	of	using	hormonal	contraception,	which	
can	be	used	by	breastfeeding	mothers,	do	not	need	to	be	
consumed	every	day	or	used	before	sexual	intercourse,	
and help to overcome cramps during menstruation and 
reduce menstrual blood.14 
According	 to	 injectable	 contraceptive	 research,	
many respondents used these methods because most 
considered	 them	 suitable	 and	 effective	 as	 they	did	not	
require	lengthy	usage	and	were	not	as	difficult	as	other	
contraception.	 The	 use	 was	 only	 1-3	 times	 a	 month,	
whereas	 contraception	 pills	 must	 be	 routinely	 taken	
every	 day	 and	 the	 user	 must	 understand	 how	 to	 take	
medication	and	people	who	do	not	know	and	use	other	
contraceptives,	might	feel	sick	and	be	afraid	of	the	risks	
of breast cancer incidence.
Breast cancer incidence: Table 2 shows that for almost 
all	 respondents,	 the	 incidence	of	breast	 cancer	did	not	
occur,	 as	many	 as	 304	 people	 (83.5%).	 This	 supports	
previous research into causes of breast cancer not only 
from	 hormonal	 contraception,	 but	 also	 age,	 genetics,	
pregnancy,	radiation,	diet	and	being	overweight.15
According	 to	 research,	 the	 occurrence	 of	 breast	
cancer because of hormonal birth control alone cannot be 
generalized as a cause of breast cancer as breast cancer 
itself	 occurs	 due	 to	 factors	 such	 as	 age,	 occupation,	
offspring,	and	not	having	children	as	well	as	hormonal	
factors. One of the hormonal factors can be obtained by 
using a long-term hormonal birth control because of the 
frequent	exposure	to	estrogen	and	progesterone,	which	
can trigger the growth of breast cancer cells.
Based	on	the	results	of	the	study,	it	showed	that	the	
majority	of	respondents	were	aged	>	35	years,	as	many	
as	50	people	(63.3%).	Women	in	their	mid-30-40s	were	
at	 risk	of	developing	breast	cancer	at	 that	age	because	
this	is	the	most	common	ages	in	which	the	first	stages	of	
breast cancer were detected.15
According	to	research,	respondents	aged	>	35	years	
were more susceptible to breast cancer because at that 
age a person experiences a decrease in the immune 
system,	so	that	they	are	easily	exposed	to	diseases,	one	
of them being breast cancer. Especially if supported by 
factors that cause breast cancer.
Based	on	the	results	of	the	study,	it	showed	that	the	
majority	 of	 respondents	 did	 not	 work,	 as	many	 as	 56	
people	(70.9).	Women	who	work	have	a	higher	risk	of	
breast	cancer,	especially	in	women	who	work	at	night,	
because the light at night can suppress the production 
of melatonin in the brain so that the hormone estrogen 
increases;	melatonin	is	believed	to	increase	breast	cancer	
cell growth.14
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According	 to	 research,	 some	 jobs	 could	 be	 a	 risk	
factor	 for	 breast	 cancer,	 such	 as	 work	 that	 is	 directly	
exposed	to	chemicals,	such	as	in	factories.	Women	who	
were	often	exposed	to	light	at	night,	such	as	watching	the	
screen of a cellphone with high light intensity for a long 
time,	could	trigger	the	growth	of	breast	cancer	cells.
Based	on	the	results	of	the	study,	it	showed	that	all	
respondents	did	not	experience	a	family	history	of	cancer,	
as	many	 as	 79	 people	 (100%).	Women	with	 offspring	
or	 who	 previously	 had	 a	 family	 member	 suffering	
from	breast	cancer	had	a	high	risk	of	developing	breast	
cancer.	About	 5-10%	 of	 breast	 cancers	 were	 reduced,	
meaning the seeds of cancer were a direct result of gene 
abnormalities (gene mutations) that were lowered from 
their parents.3	those	who	have	family	members	aged	65	
years	have	twice	the	risk,	and,	among	younger	women	
with	 breast	 cancer,	 the	more	 likely	 it	 is	 the	 disease	 is	
hereditary.15
According to the research no history of breast 
cancer	 in	 the	 family	 would	 reduce	 the	 risk	 of	 breast	
cancer. Breast cancer could also be avoided with a 
healthy	lifestyle	and	not	choosing	jobs	that	trigger	breast	
cancer.	Women	could	also	do	an	early	check-up	with	a	
health service if there were one or two family members 
who had previously had breast cancer as this could help 
to prevent the spread of cancer and allow prevention as 
soon as possible.
Based	on	the	results	of	the	study,	it	showed	that	the	
majority	 of	 respondents	 did	 not	 experience	 a	 weight	
gain	 (43	 people	 equal	 to	 54.4%).	 Women	 who	 were	
overweight after entering menopause at the age of> 35 
years	 had	 a	 higher	 risk	 of	 developing	 breast	 cancer.3 
Women	 who	 are	 overweight	 have	 a	 higher	 level	 of	
estrogen	than	they	should,	because,	before	menopause,	
the ovaries and fat tissue both produce estrogen. After 
menopause,	the	ovaries	stop	producing	estrogen	so	that	
estrogen comes from fat tissue. Having more fat tissue 
means	 increasing	 estrogen	 levels	 after	 menopause,	
thereby	increasing	the	risk	of	breast	cancer.
According	to	the	research,	there	was	no	increase	in	
body weight due to a match with the type of contraception 
used;	 those	 who	 used	 hormonal	 contraception	 were	
asked	if	they	experienced	weight	gain	or	side	effects
The correlation duration of hormonal birth control 
with breast cancer: The	 results	 of	 the	 Contingency	
Coefficient	 statistical	 test	 obtained	 a	 significant	
number	with	a	value	of	0.524,	which	means	 there	was	
a correlation between the two variables with medium 
strength and a positive direction.
Previous	 research	 stated	 that	 the	 risk	 factors	
affecting	 breast	 cancer	 incidence	 were	 the	 age	 of	 the	
respondent,	 age	 of	 menarche,	 age	 of	 menopause,	
length	 of	 breastfeeding,	 duration	 of	 oral	 contraceptive	
use,	 consumption	 patterns	 of	 fatty	 foods,	 fibrous	 food	
consumption	patterns,	obesity,	dietary	patterns,	passive	
smoking	 and	 alcohol	 consumption.16	Women	 currently	
taking	oral	 contraception	had	a	one-fourth	greater	 risk	
than	women	who	 have	 stopped	 using	 it	 10	 years	 ago,	
but	 the	 increase	 in	 risk	 is	 not	 statistically	 significant. 
This supports other studies which state that hormonal 
contraceptive use causes increased exposure to estrogen 
and	 progesterone	 hormones,	 which	 can	 cause	 cell	
proliferation in the breast glands and inhibition of the 
apoptotic process.11
According	to	the	research,	hormonal	contraception	
used > 5 years could be trusted as the cause of breast 
cancer. The incidence of breast cancer itself was usually 
detected	at	the	age	of	>	35	years,	so	that	more	women	
who	had	already	been	affected	by	 the	 impact	of	breast	
cancer,	 with	 awareness	 for	 early	 examination	 would	
certainly be able to reduce the factors that cause breast 
cancer. The use of hormonal contraception could not be 
used as a reason for breast cancer. Hormones were not 
only	obtained	from	contraception,	but	could	be	obtained	
from other drugs that contain the hormones estrogen 
and progesterone. The occurrence of breast cancer could 
be triggered from the use of hormonal contraception 
>	5	years	 and	 is	 supported	by	other	 factors,	 including	
unhealthy	 lifestyles,	 rarely	exercise,	working	 in	places	
that	were	often	exposed	to	chemicals,	and	tobacco.	The	
results of the study showed that there was a correlation 
between the use of long-term hormonal birth control and 
the	 incidence	 of	 breast	 cancer,	 even	 though	 from	 239	
respondents	and	 there	were	364	respondents	who	used	
family	planning	<	5	years,	which	means	they	had	a	lower	
risk	of	breast	cancer.
Conclusion
This study illustrates that there is a relationship 
between the duration of use of hormonal contraception 
and the incidence of breast cancer in Jombang Hospital 
with a probability value (0.000) and is supported by the 
results	of	 contingency	 statistics	with	a	value	of	0.524,	
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which means there is a correlation between two variables 
with	 moderate	 strength	 and	 positive	 direction,	 where	
the duration hormonal contraceptive use is directly 
proportional to the minimum incidence of breast cancer. 
Further	research	is	expected	to	develop	nursing	planning	
and	 increase	 knowledge	 and	 early	 detection	 of	 breast	
cancer.
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